Narrative Update • Jul 09
Have your own idea? Try our Stock Screener
German (DAX) Healthcare Sector Analysis
UpdatedJul 12, 2026
DataAggregated Company Financials
Companies64
- 7D-2.2%
- 3M9.5%
- 1Y9.1%
- YTD2.7%
Over the last 7 days, the Healthcare industry has dropped 2.2%, driven by Bayer declining 6.1%. On the other hand SCHOTT Pharma KGaA is actually up 16%. In the past year, the industry has gained 9.1%. Earnings are forecast to grow by 20% annually.
Sector Valuation and Performance
Has the German Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 12 Jul 2026 | €224.4b | €158.6b | €5.2b | 19.9x | 42.9x | 1.4x |
| Tue, 09 Jun 2026 | €203.1b | €158.5b | €5.6b | 19.1x | 36.1x | 1.3x |
| Thu, 07 May 2026 | €197.8b | €159.2b | €4.4b | 17.9x | 45.2x | 1.2x |
| Sat, 04 Apr 2026 | €198.5b | €159.3b | €4.3b | 15.9x | 46.5x | 1.2x |
| Mon, 02 Mar 2026 | €222.4b | €159.1b | €7.6b | 18x | 29.4x | 1.4x |
| Wed, 28 Jan 2026 | €228.0b | €159.2b | €7.3b | 17.2x | 31.1x | 1.4x |
| Fri, 26 Dec 2025 | €216.3b | €159.2b | €7.3b | 17.6x | 29.5x | 1.4x |
| Sun, 23 Nov 2025 | €200.4b | €159.3b | €7.4b | 16.4x | 27.1x | 1.3x |
| Tue, 21 Oct 2025 | €212.0b | €159.2b | €4.0b | 20.2x | 53.3x | 1.3x |
| Thu, 18 Sep 2025 | €200.3b | €156.7b | €4.0b | 19.5x | 50.5x | 1.3x |
| Sat, 16 Aug 2025 | €202.4b | €157.3b | €4.0b | 19.3x | 50.9x | 1.3x |
| Mon, 14 Jul 2025 | €204.4b | €159.9b | €4.2b | 21x | 48.9x | 1.3x |
| Wed, 11 Jun 2025 | €209.5b | €159.9b | €4.3b | 20.7x | 49x | 1.3x |
| Fri, 09 May 2025 | €207.8b | €158.8b | €4.7b | 23.4x | 44.1x | 1.3x |
| Sun, 06 Apr 2025 | €192.7b | €158.8b | €4.7b | 21.9x | 40.6x | 1.2x |
| Tue, 04 Mar 2025 | €224.0b | €158.5b | €6.3b | 23.9x | 35.7x | 1.4x |
| Thu, 30 Jan 2025 | €227.3b | €159.0b | €5.0b | 23.3x | 45.3x | 1.4x |
| Sat, 28 Dec 2024 | €210.7b | €159.3b | €5.0b | 22x | 42.1x | 1.3x |
| Mon, 25 Nov 2024 | €208.7b | €159.3b | €5.0b | 22.3x | 41.4x | 1.3x |
| Wed, 23 Oct 2024 | €227.7b | €159.3b | €5.7b | 21.5x | 40x | 1.4x |
| Fri, 20 Sep 2024 | €231.1b | €159.3b | €5.6b | 22.6x | 41.4x | 1.5x |
| Sun, 18 Aug 2024 | €230.7b | €159.2b | €5.6b | 26.1x | 41.5x | 1.4x |
| Tue, 16 Jul 2024 | €225.2b | €158.6b | €3.5b | 24.6x | 63.6x | 1.4x |
| Thu, 13 Jun 2024 | €239.3b | €158.6b | €3.5b | 26.3x | 67.7x | 1.5x |
| Sat, 11 May 2024 | €234.4b | €159.4b | €3.8b | 24.9x | 62.1x | 1.5x |
| Mon, 08 Apr 2024 | €237.2b | €159.1b | €3.4b | 25.2x | 70x | 1.5x |
| Wed, 06 Mar 2024 | €243.2b | €178.8b | €4.1b | 22.6x | 59.9x | 1.4x |
| Fri, 02 Feb 2024 | €241.2b | €188.4b | €3.3b | 22.5x | 73.2x | 1.3x |
| Sun, 31 Dec 2023 | €244.3b | €188.4b | €3.3b | 21.7x | 74.4x | 1.3x |
| Tue, 28 Nov 2023 | €241.6b | €188.4b | €3.3b | 23.3x | 73.6x | 1.3x |
| Thu, 26 Oct 2023 | €232.8b | €189.3b | €8.6b | 21.4x | 26.9x | 1.2x |
| Sat, 23 Sep 2023 | €254.2b | €189.5b | €8.8b | 22.4x | 29x | 1.3x |
| Mon, 21 Aug 2023 | €258.9b | €189.4b | €8.9b | 24.2x | 29.2x | 1.4x |
| Wed, 19 Jul 2023 | €260.2b | €191.1b | €10.5b | 24x | 24.7x | 1.4x |
Price to Earnings Ratio
24.7x
Current Industry PE
- Investors are pessimistic on the German Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 42.9x which is lower than its 3-year average PE of 47.6x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 21% per year over the last three years,
- Revenues have also declined 6.0% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare sector?
| DE Market | -2.52% | |
| Healthcare | -2.16% | |
| Life Sciences | 7.31% | |
| Healthtech | 0.84% | |
| Healthcare Services | 0.64% | |
| Biotech | -1.20% | |
| Medical Equipment | -1.31% | |
| Pharma | -4.93% | |
Industry PE
- Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 135x.
- Analysts are expecting annual earnings growth of 24.0%, which is lower than the prior year's growth of 39.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 84% over the next 5 years.
- This is better than its past earnings decline of 91% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1SXP SCHOTT Pharma KGaA | €20.20 | 15.8% +€415.7m | -22.3% | PE21.3x | |
| FME Fresenius Medical Care | €41.93 | 2.0% +€195.6m | -9.4% | PE11.8x | |
| AFX Carl Zeiss Meditec | €30.60 | 6.5% +€162.8m | -41.2% | PE28.2x | |
| FRE Fresenius SE KGaA | €42.57 | 0.3% +€78.9m | 1.5% | PE15.8x | |
| GXI Gerresheimer | €28.48 | 1.2% +€11.7m | -41.9% | PS0.4x |
